Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Axsome Therapeutics Inc. (AXSM)
:AXSM
AXSM Analyst Ratings
Strong Buy
18 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AXSM Stock 12 Month Forecast
Average Price Target
$163.63
▲(26.75% Upside)
| Highest Price Target$200.00 | Average Price Target$163.63 | Lowest Price Target$117.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
Reiterated
02/20/25
Truist Financial
Reiterated
02/19/25
Guggenheim
Reiterated
02/19/25
Needham
Reiterated
02/19/25
Cantor Fitzgerald
Reiterated
02/18/25
RBC Capital
Reiterated
02/18/25
Bank of America Securities
Reiterated
02/18/25
Wells Fargo
Reiterated
02/18/25
TD Cowen
Reiterated
02/18/25
Mizuho Securities
Reiterated
02/18/25
Leerink Partners
$110→$150
Buy
16.19%
Upside
Reiterated
02/11/25
Analyst Upgrades Axsome to Buy Amid Key Settlement with Teva and Raised Price Target
Deutsche Bank
$176
Buy
36.33%
Upside
Initiated
02/11/25
Axsome Therapeutics initiated with a Buy at Deutsche BankAxsome Therapeutics initiated with a Buy at Deutsche Bank
UBS
$105→$133
Buy
3.02%
Upside
Reiterated
02/11/25
Axsome Therapeutics (AXSM) PT Raised to $133 at UBSUBS analyst Ashwani Verma raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $133.00 (from $105.00) while maintaining a Buy rating.
Robert W. Baird
$116→$132
Buy
2.25%
Upside
Reiterated
02/03/25
Axsome Therapeutics price target raised to $132 from $116 at BairdAxsome Therapeutics price target raised to $132 from $116 at Baird
Morgan Stanley
$125
Buy
-3.18%
Downside
Reiterated
01/30/25
Axsome Therapeutics' Promising Market Potential Following FDA Approval of Symbravo for Acute Migraine
Best Analysts Covering Axsome Therapeutics
Which Analyst Should I Follow If I Want to Buy AXSM and Sell After:
1 Month
xxx
Success Rate
15/22 ratings generated profit
Average Return
+17.98%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 68.18% of your transactions generating a profit, with an average return of +17.98% per trade.
3 Months
xxx
Success Rate
16/22 ratings generated profit
Average Return
+48.47%
reiterated a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 72.73% of your transactions generating a profit, with an average return of +48.47% per trade.
1 Year
Success Rate
14/15 ratings generated profit
Average Return
+22.88%
reiterated a buy rating 2 days ago
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 93.33% of your transactions generating a profit, with an average return of +22.88% per trade.
2 Years
xxx
Success Rate
15/15 ratings generated profit
Average Return
+33.97%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +33.97% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
AXSM Analyst Recommendation Trends
Rating
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Strong Buy
9
9
13
16
16
Buy
28
40
42
48
47
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
37
49
55
64
63
Each month's total comprises the sum of three months' worth of ratings.
AXSM Financial Forecast
AXSM Stock Forecast FAQ
What is AXSM’s average 12-month price target, according to analysts?
Based on analyst ratings, Axsome Therapeutics Inc.’s 12-month average price target is $163.63.
What is AXSM’s upside potential, based on the analysts’ average price target?
Axsome Therapeutics Inc. has 26.75% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AXSM a Buy, Sell or Hold?
Axsome Therapeutics Inc. has a consensus rating of Strong Buy which is based on 18 buy ratings, 0 hold ratings and 0 sell ratings.
What is Axsome Therapeutics Inc.’s price target?
The average price target for Axsome Therapeutics Inc. is $163.63. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $200.00 ,the lowest forecast is $117.00. The average price target represents 26.75% Increase from the current price of $129.1.
The highest analyst price target is $200.00 ,the lowest forecast is $117.00. The average price target represents 26.75% Increase from the current price of $129.1.
What do analysts say about Axsome Therapeutics Inc.?
Axsome Therapeutics Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.
How can I buy shares of AXSM?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.